Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Folegatti PM. et al, (2020), The Lancet, 396, 467 - 478

Reduced Ebola vaccine responses in CMV+ young adults is associated with expansion of CD57+KLRG1+ T cells.

Bowyer G. et al, (2020), The Journal of experimental medicine, 217

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.

Folegatti PM. et al, (2020), The Lancet. Infectious diseases, 20, 816 - 826

Risk of pneumococcal bacteremia in Kenyan children with glucose-6-phosphate dehydrogenase deficiency.

Gilchrist JJ. et al, (2020), BMC medicine, 18

The Human Leukocyte Antigen Locus and Rheumatic Heart Disease Susceptibility in South Asians and Europeans.

Auckland K. et al, (2020), Scientific reports, 10

Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.

Cappuccini F. et al, (2020), Journal for immunotherapy of cancer, 8

Targeting Antigen to the Surface of EVs Improves the In Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice.

Bliss CM. et al, (2020), Molecular therapy. Methods & clinical development, 16, 108 - 125

Estimating the burden of iron deficiency among African children.

Muriuki JM. et al, (2020), BMC medicine, 18

Vaccine innovations for emerging infectious diseases-a symposium report.

Cable J. et al, (2020), Annals of the New York Academy of Sciences, 1462, 14 - 26

Identification of antigens presented by MHC for vaccines against tuberculosis.

Bettencourt P. et al, (2020), NPJ Vaccines, 5

Generation of Novel Plasmodium falciparum NF135 and NF54 Lines Expressing Fluorescent Reporter Proteins Under the Control of Strong and Constitutive Promoters.

Miyazaki S. et al, (2020), Frontiers in Cellular and Infection Microbiology, 10

The Ratiometric Transcript Signature MX2/GPR183 Is Consistently Associated With RTS,S-Mediated Protection Against Controlled Human Malaria Infection.

Du Y. et al, (2020), Frontiers in Immunology, 11

Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats

Stedman A. et al, (2019), npj Vaccines, 4

Identification of novel mycobacterial antigens presented by MHC-I and -II by immunopeptidomics for vaccines against tuberculosis

Bettencourt P. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1691 - 1691

The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremia.

Muriuki JM. et al, (2019), Science advances, 5

Identification of host-pathogen-disease relationships using a scalable Multiplex Serology platform in UK Biobank

Mentzer AJ. et al, (2019)

Host genetic variants near the PAX5 gene locus associate with susceptibility to invasive group A streptococcal disease

Parks T. et al, (2019)

TMEM203 is a binding partner and regulator of STING-mediated inflammatory signaling in macrophages.

Li Y. et al, (2019), Proc Natl Acad Sci U S A

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data.

Romagnoni A. et al, (2019), Sci Rep, 9

A phase IIb study to determine the safety and efficacy of candidate INfluenza Vaccine MVA-NP+M1 in combination with licensed InaCTivated inflUenza vaccine in adultS aged 65 years and above (INVICTUS): a study protocol

Swayze H. et al, (2019), F1000Research, 8, 719 - 719

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?